Mutations in the TP53 Gene in Cervical Carcinomas with Low HPV Load
Author Information
Author(s): A Helland, F Karlsen, EU Due, R Holand, G Kristensen, A-L Borresen-Dale
Primary Institution: The Norwegian Radium Hospital
Hypothesis
Is p53 inactivation essential in the development of cervical carcinomas with low or no HPV load?
Conclusion
The study found a significant mutation frequency in the TP53 gene among cervical carcinomas with low or no HPV load.
Supporting Evidence
- 42% of the samples showed mutations in the TP53 gene.
- Elevated p53 protein expression was significantly associated with the presence of a mutation.
- 16 out of 19 carcinomas showed p21 protein expression.
Takeaway
This study looked at cervical cancer samples with little or no HPV and found that many had mutations in a gene called TP53, which is important for stopping cancer.
Methodology
The study analyzed 19 cervical carcinoma samples for TP53 mutations and protein expression using CDGE and immunohistochemistry.
Limitations
The study only included samples with low or no HPV load, which may not represent all cervical carcinomas.
Participant Demographics
Patients with primary cervical carcinomas admitted to the Department of Gynaecological Oncology from 1988 to 1993.
Statistical Information
P-Value
p<0.007
Statistical Significance
p<0.001
Want to read the original?
Access the complete publication on the publisher's website